| UniProt ID | VASN_HUMAN | |
|---|---|---|
| UniProt AC | Q6EMK4 | |
| Protein Name | Vasorin | |
| Gene Name | VASN | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 673 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein . Secreted . |
|
| Protein Description | May act as an inhibitor of TGF-beta signaling.. | |
| Protein Sequence | MCSRVPLLLPLLLLLALGPGVQGCPSGCQCSQPQTVFCTARQGTTVPRDVPPDTVGLYVFENGITMLDAGSFAGLPGLQLLDLSQNQIASLPSGVFQPLANLSNLDLTANRLHEITNETFRGLRRLERLYLGKNRIRHIQPGAFDTLDRLLELKLQDNELRALPPLRLPRLLLLDLSHNSLLALEPGILDTANVEALRLAGLGLQQLDEGLFSRLRNLHDLDVSDNQLERVPPVIRGLRGLTRLRLAGNTRIAQLRPEDLAGLAALQELDVSNLSLQALPGDLSGLFPRLRLLAAARNPFNCVCPLSWFGPWVRESHVTLASPEETRCHFPPKNAGRLLLELDYADFGCPATTTTATVPTTRPVVREPTALSSSLAPTWLSPTEPATEAPSPPSTAPPTVGPVPQPQDCPPSTCLNGGTCHLGTRHHLACLCPEGFTGLYCESQMGQGTRPSPTPVTPRPPRSLTLGIEPVSPTSLRVGLQRYLQGSSVQLRSLRLTYRNLSGPDKRLVTLRLPASLAEYTVTQLRPNATYSVCVMPLGPGRVPEGEEACGEAHTPPAVHSNHAPVTQAREGNLPLLIAPALAAVLLAALAAVGAAYCVRRGRAMAAAAQDKGQVGPGAGPLELEGVKVPLEPGPKATEGGGEALPSGSECEVPLMGFPGPGLQSPLHAKPYI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 45 | Phosphorylation | CTARQGTTVPRDVPP EECCCCCCCCCCCCC | 35.02 | 28857561 | |
| 101 | N-linked_Glycosylation | GVFQPLANLSNLDLT CCHHHCCCCCCCCCC | 52.24 | 19159218 | |
| 117 | N-linked_Glycosylation | NRLHEITNETFRGLR HHHHHHHHHHHHHHH | 52.55 | 22171320 | |
| 224 | Phosphorylation | NLHDLDVSDNQLERV CCCCCCCCCCHHHCC | 30.43 | - | |
| 273 | N-linked_Glycosylation | LQELDVSNLSLQALP HHHCCCCCCCCCCCC | 33.23 | 16335952 | |
| 284 | Phosphorylation | QALPGDLSGLFPRLR CCCCCCHHCHHHHHH | 37.88 | 29496963 | |
| 319 | O-linked_Glycosylation | WVRESHVTLASPEET CCEECCEEECCCCCC | 15.93 | 55830571 | |
| 378 | Phosphorylation | LSSSLAPTWLSPTEP CCCCCCCCCCCCCCC | 33.17 | 25332170 | |
| 454 | O-linked_Glycosylation | QGTRPSPTPVTPRPP CCCCCCCCCCCCCCC | 34.43 | OGP | |
| 454 | Phosphorylation | QGTRPSPTPVTPRPP CCCCCCCCCCCCCCC | 34.43 | 23684312 | |
| 457 | Phosphorylation | RPSPTPVTPRPPRSL CCCCCCCCCCCCCCE | 18.13 | 25332170 | |
| 463 | O-linked_Glycosylation | VTPRPPRSLTLGIEP CCCCCCCCEEECCEE | 31.32 | OGP | |
| 463 | Phosphorylation | VTPRPPRSLTLGIEP CCCCCCCCEEECCEE | 31.32 | 29396449 | |
| 465 | O-linked_Glycosylation | PRPPRSLTLGIEPVS CCCCCCEEECCEECC | 24.96 | OGP | |
| 465 | Phosphorylation | PRPPRSLTLGIEPVS CCCCCCEEECCEECC | 24.96 | 29396449 | |
| 472 | O-linked_Glycosylation | TLGIEPVSPTSLRVG EECCEECCCCHHHHH | 32.93 | OGP | |
| 474 | O-linked_Glycosylation | GIEPVSPTSLRVGLQ CCEECCCCHHHHHHH | 32.65 | OGP | |
| 475 | O-linked_Glycosylation | IEPVSPTSLRVGLQR CEECCCCHHHHHHHH | 19.98 | OGP | |
| 487 | O-linked_Glycosylation | LQRYLQGSSVQLRSL HHHHHCCCCEEEEEE | 17.86 | 55832923 | |
| 493 | Phosphorylation | GSSVQLRSLRLTYRN CCCEEEEEEEEEEEC | 26.83 | 22210691 | |
| 498 | Phosphorylation | LRSLRLTYRNLSGPD EEEEEEEEECCCCCC | 11.33 | - | |
| 500 | N-linked_Glycosylation | SLRLTYRNLSGPDKR EEEEEEECCCCCCCE | 28.30 | UniProtKB CARBOHYD | |
| 510 | Phosphorylation | GPDKRLVTLRLPASL CCCCEEEEEECCHHH | 15.68 | 21712546 | |
| 516 | O-linked_Glycosylation | VTLRLPASLAEYTVT EEEECCHHHHEEEEH | 26.60 | 55829943 | |
| 520 | Phosphorylation | LPASLAEYTVTQLRP CCHHHHEEEEHHCCC | 10.82 | 25332170 | |
| 521 | Phosphorylation | PASLAEYTVTQLRPN CHHHHEEEEHHCCCC | 14.47 | 25332170 | |
| 528 | N-linked_Glycosylation | TVTQLRPNATYSVCV EEHHCCCCCEEEEEE | 38.18 | UniProtKB CARBOHYD | |
| 530 | O-linked_Glycosylation | TQLRPNATYSVCVMP HHCCCCCEEEEEEEE | 23.99 | OGP | |
| 532 | O-linked_Glycosylation | LRPNATYSVCVMPLG CCCCCEEEEEEEECC | 12.51 | OGP | |
| 555 | O-linked_Glycosylation | EACGEAHTPPAVHSN HCCCCCCCCCCCCCC | 37.71 | OGP | |
| 567 | O-linked_Glycosylation | HSNHAPVTQAREGNL CCCCCCCCCCCCCCC | 18.56 | 55829627 | |
| 612 | Ubiquitination | MAAAAQDKGQVGPGA HHHHHHCCCCCCCCC | 38.88 | 21906983 | |
| 628 | Ubiquitination | PLELEGVKVPLEPGP CCEEECEEEECCCCC | 49.33 | 21963094 | |
| 636 | Ubiquitination | VPLEPGPKATEGGGE EECCCCCCCCCCCCC | 74.07 | 29967540 | |
| 638 | Phosphorylation | LEPGPKATEGGGEAL CCCCCCCCCCCCCCC | 41.09 | 29514088 | |
| 647 | Phosphorylation | GGGEALPSGSECEVP CCCCCCCCCCEEEEE | 56.66 | 27050516 | |
| 649 | Phosphorylation | GEALPSGSECEVPLM CCCCCCCCEEEEEEC | 43.33 | 29514088 | |
| 665 | Phosphorylation | FPGPGLQSPLHAKPY CCCCCCCCCCCCCCC | 34.18 | 22199227 | |
| 670 | Ubiquitination | LQSPLHAKPYI---- CCCCCCCCCCC---- | 27.83 | 29967540 | |
| 672 | Phosphorylation | SPLHAKPYI------ CCCCCCCCC------ | 20.68 | 18669648 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VASN_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VASN_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VASN_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD."; Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.; Mol. Cell. Proteomics 0:0-0(2011). Cited for: GLYCOSYLATION AT ASN-117, STRUCTURE OF CARBOHYDRATES, AND MASSSPECTROMETRY. | |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-101 AND ASN-273, AND MASSSPECTROMETRY. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-117 AND ASN-273, AND MASSSPECTROMETRY. | |